Those investigators specifically introduced a tamoxifen-inducible deletion of PPP2CA in the heart and observed cardiac hypertrophy and its accompanying fibrosis 2 months after ablation of PPP2CA32. Here, PPP2CA is linked to cardiac hypertrophy.